| |
|
|
|
Evofem Biosciences Inc.  
|
|
5.01 0.23 (0.05%) |
08-21 16:00 |
|
Open: |
4.81 |
Pre close: |
4.78 |
Target:
|
6.26 
|
|
High: |
5.25 |
Low: |
4.7643 |
Resistance:
|
5.36
5.74
|
|
Volume: |
28,592 |
Market Cap: |
233M |
Support:
|
4.73
3.94
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.96
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
5.09 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
5.11 |
Stochastic Oscillator |
%K(14,3):
|
15.84 |
|
MA(250): |
4.23 |
%D(3): |
19.15 |
|
Average Volume(K) |
3-Month: |
10265
|
52-Week |
High:
|
7.24 |
|
10-Days: |
2944 |
Low: |
2.25 |
|
RSI |
RSI(14):
|
47.40 |
Change(%): |
114.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.008 |
Return on Equity (ttm) |
-423.5 |
Shares Out. (M) |
17.76 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-91.5 |
Shares Float (M) |
32.01 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
-0.11 |
% Held by Insiders |
4.07 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
76.45 |
|
Forward EPS |
-1.520 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
241 |
|
Book Value (p.s.) |
0.770 |
EBITDA (p.s.) |
-3.306 |
P/E |
-1.67 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.40 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-28.86 |
P/CF |
-1.92 |
|
|
|
|
|
|
